Prevention of recurrent deep-vein thrombosis
The aim of this review is to outline recent randomized controlled trials and strategies that have tested various methods that aim to reduce the risk of recurrent venous thromboembolism (VTE) after the completion of anticoagulant therapy. Aspirin reduced VTE recurrence by approximately 30% (hazard ra...
Main Author: | Andrew N Nicolaides |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Vascular Investigation and Therapy |
Subjects: | |
Online Access: | http://www.vitonline.org/article.asp?issn=2589-9686;year=2019;volume=2;issue=1;spage=19;epage=23;aulast=Nicolaides |
Similar Items
-
Assessment and predictors of inappropriate dose of direct oral anticoagulants
by: Mosaad O. Almegren
Published: (2024-01-01) -
Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis
by: Attard LM, et al.
Published: (2022-10-01) -
HOW NEW APPROACHES TO THE TREATMENT OF PULMONARY EMBOLISM AFFECT THE OUTCOME OF THE DISEASE?
by: M. Y. Gilyarov, et al.
Published: (2017-12-01) -
Utilization and prescribing patterns of direct oral anticoagulants
by: Whitworth MM, et al.
Published: (2017-03-01) -
Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery
by: Antonijević Nebojša, et al.
Published: (2020-01-01)